GeneDx Holdings (WGS) Gross Profit Growth (3y) (2023 - 2026)
GeneDx Holdings (WGS) Gross Profit Growth (3y) (2023 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Gross Profit Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Thermo Fisher Scientific | 213.88 Bn | 209.81 Bn | 8.34 Bn | 4.04% |
| 2 | Danaher | 140.65 Bn | 136.30 Bn | 3.61 Bn | 2.86% |
| 3 | Idexx Laboratories | 46.02 Bn | 45.83 Bn | 779.09 Mn | 10.79% |
| 4 | Agilent Technologies | 39.85 Bn | 38.05 Bn | 990.00 Mn | 2.33% |
| 5 | Iqvia Holdings | 39.20 Bn | 37.12 Bn | 1.44 Bn | 3.75% |
| 6 | Natera | 38.80 Bn | 37.70 Bn | 696.04 Mn | 94.91% |
| 7 | Illumina | 30.11 Bn | 28.94 Bn | 770.00 Mn | 1.70% |
| 8 | Mettler Toledo International | 28.66 Bn | 28.61 Bn | 650.22 Mn | 3.67% |
| 9 | Quest Diagnostics | 26.24 Bn | 25.61 Bn | 1.03 Bn | 9.05% |
| 10 | GeneDx Holdings | 2.08 Bn | 1.94 Bn | 78.24 Mn | 60.97% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 60.97% |
| Mar 31, 2026 | 64.81% |
| Dec 31, 2025 | 92.75% |
| Sep 30, 2025 | 84.09% |
| Jun 30, 2025 | 63.81% |
| Mar 31, 2025 | 118.25% |
| Dec 31, 2024 | 194.70% |
| Sep 30, 2024 | 97.95% |
| Jun 30, 2024 | 238.83% |
| Mar 31, 2024 | 120.04% |
| Dec 31, 2023 | 95.05% |
| Sep 30, 2023 | 76.60% |
| Jun 30, 2023 | 84.30% |
| Mar 31, 2023 | 16.98% |